Furthermore, within our consortium, Interleukin 8 (IL-8) [13], Calgizzarin (S100A11) [14] and complement component 3a (C3adesArg) [15] serum levels were determined as potentially promising biomarkers for CRC [14]. Here, S100A11 is linked to colorectal carcinoma.